Abstract:Background: Intratympanic injections of glucocorticoids have become increasingly common in the treatment of idiopathic sudden sensorineural hearing loss (ISSHL). However, due to their fast elimination, sustained applications have been suggested for local drug delivery to the inner ear. Materials and methods: The study is based on a retrospective chart review of patients treated for ISSHL at a single tertiary (university) referral center. We included patients who were treated with a solid, biodegradable, poly(D,L-lactic-co-glycolic acid) (PLGA)-based drug delivery system providing sustained delivery of dexamethasone extracochlear into the round window niche ( n = 15) or intracochlear into scala tympani ( n = 2) for tertiary therapy of ISSHL in patients without serviceable hearing after primary systemic and secondary intratympanic glucocorticoid therapy. We evaluated the feasibility and safety through clinical evaluation, histological examination, and functional tests [pure-tone threshold (PTA), word recognition scores (WRS)]. Results: With adequate surgical preparation of the round window niche, implantation was feasible in all patients. Histologic examination of the material in the round window niche showed signs of resorption without relevant inflammation or foreign body reaction to the implant. In patients where the basal part of scala tympani was assessable during later cochlear implantation, no pathological findings were found. In the patients with extracochlear application, average preoperative PTA was 84.7 dB HL (SD: 20.0) and 76.7 dB HL (SD: 16.7) at follow-up ( p = 0.08). The preoperative average maximum WRS was 14.6% (SD: 17.9) and 39.3% (SD: 30.7) at follow-up ( p = 0.11). Six patients (40%), however, reached serviceable hearing. The two patients with intracochlear application did not improve. Conclusion: The extracochlear application of the controlled release system in the round window niche and – based on limited observations - intracochlear implantation into scala tympani appears feasible and safe. Due to the uncontrolled study design, conclusions about the efficacy of the treatment are limited. These observations, however, may encourage the initiation of prospective controlled studies using biodegradable controlled release implants as drug delivery systems for the treatment of inner ear diseases.

Surgical procedure of intratympanic injection and inner ear pharmacokinetics simulation in domestic pigs

Local Long-Term Inner Ear Drug Delivery in Normal Hearing Guinea Pig—An Animal Model to Develop Preventive Treatment for Noise-Induced Hearing Loss

Insertion trauma of a novel inner ear catheter for intracochlear drug delivery

Postauricular Hypodermic Injection to Treat Inner Ear Disorders: Experimental Feasibility Study Using Magnetic Resonance Imaging and Pharmacokinetic Comparison

Comparison of the Pathway to the Inner Ear Between Postauricular and Intramuscular Injection of Dexamethasone in Guinea Pigs

Mastoid approach for local drug delivery to the inner ear for treating hearing loss

Feasibility study of inner ear drug delivery via post-auricular injection using 7.0 Tesla MRI

Miniature Pigs: a Large Animal Model of Cochlear Implantation.

Microneedles Facilitate Small-Volume Intracochlear Delivery Without Physiologic Injury in Guinea Pigs

Dexamethasone Pharmacokinetics in Guinea Pig Inner Ear Perilymph

Inner Ear Structure of Miniature Pigs Measured by Multi-Planar Reconstruction Techniques

Adult porcine (Sus scrofa) derived inner ear cells: Characteristics in in-vitro cultures

Dexamethasone levels and base-to-apex concentration gradients in the scala tympani perilymph after intracochlear delivery in the guinea pig

Molded Round Window Niche Implant as a Dexamethasone Delivery System in a Cochlear Implant-Trauma Animal Model

Development of a drug delivering round window niche implant for cochlear pharmacotherapy

The morphology of the inner ear from the domestic pig (Sus scrofa)

Improved intracochlear biopolymeric drug delivery system: an in vivo study

An animal model for the analysis of cochlear blood flood disturbance and hearing threshold in vivo

Evaluation of a transtympanic delivery system in Mus musculus for extended release steroids

Guinea Pig Round Window Membrane Explantation for Ex Vivo Studies

Safety and audiological outcome in a case series of tertiary therapy of sudden hearing loss with a biodegradable drug delivery implant for controlled release of dexamethasone to the inner ear